Target intelligence / Profile preview

U1 small nuclear RNA 19, pseudogene (RNU1-19P)

Target
RNU1-19P
Molecular classification
Pseudogene, Non-coding RNA, Small nuclear RNA (snRNA, pseudogene-derived)
01

Overview

U1 small nuclear RNA is an essential component of the spliceosome complex, required for the splicing of pre-mRNA in eukaryotes[1][2]. U1 snRNA mediates recognition of the 5' splice site on pre-mRNA and is crucial for initiating spliceosome assembly and regulated gene expression[1][2]. The RNU1-19P locus is a pseudogene: a DNA sequence with close similarity to active U1 snRNA genes but containing mutations or deletions preventing it from encoding the canonical snRNA[1][3]. Pseudogenes of U1 snRNA, such as RNU1-19P, are typically located in the 1q12–21 region of chromosome 1 and are considered "class I" pseudogenes[1][3]. Historically, such pseudogenes were presumed non-functional, but recent evidence suggests some U1 snRNA pseudogenes can be transcribed and may produce variant snRNA molecules that play regulatory roles in mRNA processing. However, for RNU1-19P specifically, there is no evidence for direct functional activity, no validated disease association, and it is not a therapeutic target[1]. Interpretation and notes: - This target is a pseudogene, not a canonical receptor, enzyme, transporter, or transcription factor. - There are no drugs or clinical biomarkers associated with this entity. - It should be considered not a therapeutic target. - The symbol/name suggests it could be confused with functional U1 snRNA or with U1 snRNP (spliceosome protein complex), which are essential for splicing, but RNU1-19P itself is not a functional target[1][3]. - Pseudogenes may be transcribed and could conceivably have regulatory functions, but there is no direct evidence for this specific locus.

Other names
RNU1-19PU1 snRNA 19 pseudogeneU1 small nuclear 19 pseudogeneU1 snRNA class I pseudogene
02

Mechanism of action

Not applicable; no approved drugs target this pseudogene

03

Biological functions

Possible regulation of pre-mRNA processing (variant U1 snRNAs)Potential decoy or regulatory RNA roles if transcribed
04

Disease associations

None specifically attributed to this pseudogene; no direct evidence links RNU1-19P to disease
05

Safety considerations

None reported

Beyond the preview

Go deeper on U1 small nuclear RNA 19, pseudogene (RNU1-19P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U1 small nuclear RNA 19, pseudogene (RNU1-19P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call